GCN1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.428200E-01
Normal-vs-Stage2
4.709400E-01
Normal-vs-Stage3
1.234820E-01
Normal-vs-Stage4
5.251600E-01
Stage1-vs-Stage2
8.354400E-01
Stage1-vs-Stage3
1.193770E-01
Stage1-vs-Stage4
9.112400E-01
Stage2-vs-Stage3
1.254210E-01
Stage2-vs-Stage4
9.458200E-01
Stage3-vs-Stage4
1.899770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.954600E-01
Normal-vs-AfricanAmerican
3.789800E-01
Normal-vs-Asian
2.001800E-01
Caucasian-vs-AfricanAmerican
8.103000E-01
Caucasian-vs-Asian
4.246200E-01
AfricanAmerican-vs-Asian
6.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.367800E-01
Normal-vs-Female
4.016400E-01
Male-vs-Female
3.819000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.554600E-01
Normal-vs-Age(41-60Yrs)
5.562400E-01
Normal-vs-Age(61-80Yrs)
4.077800E-01
Normal-vs-Age(81-100Yrs)
6.521600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.389600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.421200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.616200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.274600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.213000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.680200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.753200E-01
Normal-vs-Daily Drinker
3.387800E-01
Normal-vs-Weekly Drinker
6.283000E-01
Normal-vs-Occasional Drinker
6.946200E-01
Normal-vs-Social Drinker
7.376200E-01
Non Drinker-vs-Daily Drinker
7.755800E-01
Non Drinker-vs-Weekly Drinker
4.503200E-01
Non Drinker-vs-Occasional Drinker
9.397800E-02
Non Drinker-vs-Social Drinker
1.575990E-01
Daily Drinker-vs-Weekly Drinker
6.162800E-01
Daily Drinker-vs-Occasional Drinker
1.775580E-01
Daily Drinker-vs-Social Drinker
2.644400E-01
Weekly Drinker-vs-Occasional Drinker
6.184600E-01
Weekly Drinker-vs-Social Drinker
6.731200E-01
Occasional Drinker-vs-Social Drinker
9.581800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.176200E-01
Normal-vs-Grade 2
9.000000E-02
Normal-vs-Grade 3
8.400000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.079600E-01
Grade 1-vs-Grade 3
4.703800E-01
Grade 1-vs-Grade 4
2.176200E-01
Grade 2-vs-Grade 3
1.405570E-01
Grade 2-vs-Grade 4
9.000000E-02
Grade 3-vs-Grade 4
8.400000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.871600E-01
Normal-vs-NonDiabetic
4.327800E-01
Diabetic-vs-NonDiabetic
3.400400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.362200E-01
Normal-vs-NoPancreatitis
4.207000E-01
Pancreatitis-vs-NoPancreatitis
9.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.699600E-01
Normal-vs-N1
4.615600E-01
N0-vs-N1
8.841800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.528200E-01
Normal-vs-TP53-NonMutant
6.935000E-01
TP53-Mutant-vs-TP53-NonMutant
7.809200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
